If you're an income investor looking for dividends to boost your income, then you may want to consider the ASX shares listed below.

Both of these ASX dividend shares have been rated as buys and tipped to provide investors with attractive yields in the coming years.

Here's what you need to know about these shares:

Dexus Industria REIT (ASX: DXI)

Morgans is tipping this industrial and office property company as a dividend share to buy.

That's because it believes Dexus Industria is well-placed for growth thanks to strong demand in the industrial market.

The broker currently has an add rating and $3.37 price target on the company's shares. It commented:

DXI's key industrial markets remain robust with the outlook for solid rental growth backed by strong tenant demand. The development pipeline also provides near and medium term upside potential.

As for dividends, the broker is forecasting dividends per share of 16.5 cents in FY 2023 and 16.8 cents in FY 2024. Based on the current Dexus Industria share price of $2.97, this will mean yields of 5.6% and 5.7%, respectively.

Healthco Healthcare and Wellness REIT (ASX: HCW)

Another ASX dividend share for income investors to consider is the Healthco Healthcare and Wellness REIT.

This health and wellness focused real estate investment trust invests in properties including hospitals, aged care, childcare, government, life sciences and research, and primary care and wellness properties.

Analysts at Morgans are also positive on Healthco Healthcare and Wellness REIT and have an add rating and $2.06 price target on its shares. The broker was pleased with its performance during the first half. It commented:

1H23 result highlights included solid operational performance of the existing portfolio; completion of the George Private Hospital; a new accretive acquisition of a life sciences asset; stable net valuation movements (NTA $2.00); as well as a 4% upgrade to FY23 FFO guidance.

As for dividends, Morgans is expecting in dividends per share of 7.5 cents in FY 2023 and 7.8 cents FY 2024. Based on the current Healthco Healthcare and Wellness REIT unit price of $1.58, this will mean yields of 4.75% and 4.9%, respectively, for investors.

The post Grow your passive income with these ASX dividend shares: brokers appeared first on The Motley Fool Australia.

With so many shares to choose from on the ASX, it can be hard to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares that leading brokers have named as buys this week are listed below. Here's why they are bullish on them:

Aristocrat Leisure Limited (ASX: ALL)

According to a note out of Morgan Stanley, its analysts have retained their overweight rating and $43.00 price target on this gaming technology company's shares. This follows news that Aristocrat's real money gaming (RMG) business has signed a deal with BetMGM for digital slot content. BetMGM believes the deal will makes its online casino the best destination for players. Morgan Stanley believes this is a big positive for Aristocrat and its fledgling RMG business. The Aristocrat share price is trading at $35.70 on Monday.

Healthco Healthcare and Wellness REIT (ASX: HCW)

A note out of Morgans reveals that its analysts have retained their add rating on this property company's shares with an improved price target of $2.06. This follows the release of the company's half year results, which revealed a solid operational performance. Morgans appears positive on the future, highlighting its active development pipeline (Springfield and Proxima) and the uncommitted developments which include strategic partners. The Healthco share price is fetching $1.55 today.

Objective Corporation Limited (ASX: OCL)

Analysts at Goldman Sachs have retained their buy rating but trimmed their price target on this software company's shares to $14.80. Although Objective Corp's half year results came in below expectations on both ARR growth and costs/margins, Goldman believes the company has reached an earnings trough after making the decision to reduce its one-off revenue sources and reinvest into growth initiatives. The Objective Corp share price is trading at $12.48 this afternoon.

The post Leading brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.

Are you looking for dividend shares to buy? If you are, you may want to check out the two listed below that have been tipped to provide attractive yields.

Here's what you need to know about these ASX dividend shares today:

Elders Ltd (ASX: ELD)

The first ASX dividend share that could be a buy is Elders.

It is an Australian agribusiness company that provides a range of services to rural and regional customers primarily in Australia and New Zealand. It also operates red meat supply chains in Indonesia and China.

Goldman Sachs is a fan of the company. This is due to the Australian agricultural environment being structurally strong and Elders being uniquely placed to benefit as a highly diversified agribusiness with broad geographic and segment exposure.

It also notes that farmer balance sheets and industry data hint at strong intentions for investment and expanded production in response to a tightening global agricultural market.

In respect to dividends, the broker is expecting fully franked dividends per share of 53 cents in FY 2023 and 57 cents in FY 2024. Based on the current Elders share price of $8.93, this will mean yields of 5.9% and 6.4%, respectively.

Goldman Sachs currently has a conviction buy rating and $18.40 price target on the company's shares.

Healthco Healthcare and Wellness REIT (ASX: HCW)

Another ASX dividend share that has been tipped as a buy is Healthco Healthcare and Wellness.

It is a real estate investment trust with a mandate to invest in healthcare and wellness assets. These include hospitals, aged care, childcare, government, life sciences and research, and primary care and wellness property assets.

Morgans is positive on the company and is expecting some attractive yields from its shares in the coming years. It is forecasting dividends per share of 8 cents in both FY 2023 and FY 2024. Based on the current Healthco Healthcare and Wellness REIT unit price of $1.54, this will mean yields of 5.2% for investors.

Morgans has an add rating and $2.05 price target on its shares.

The post Get 5%+ yields from these top ASX dividend shares: experts appeared first on The Motley Fool Australia.

If you're an income investor looking for dividends to boost your passive income, then you may want to consider the ASX dividend shares named below.

Both of these ASX dividend shares have been rated as buys and tipped to provide investors with attractive yields in the coming years.

Here's what you need to know about these shares:

Healthco Healthcare and Wellness REIT (ASX: HCW)

The first ASX dividend share for income investors to consider is the Healthco Healthcare and Wellness REIT.

This health and wellness focused real estate investment trust invests in properties including hospitals, aged care, childcare, government, life sciences and research, and primary care and wellness properties.

Analysts at Goldman Sachs are positive on the company and have a conviction buy rating and $2.14 price target on its shares.

Goldman advised that it is a fan of Healthco Healthcare and Wellness due to its strong balance sheet and its exposure to government-backed sub-sectors. It believes this makes it one of the "top picks in the sector."

As for dividends, Goldman is expecting dividends per share of 7.5 cents in both FY 2023 and FY 2024. Based on the current Healthco Healthcare and Wellness REIT unit price of $1.72, this will mean yields of 4.35% for investors.

National Australia Bank Ltd (ASX: NAB)

Goldman Sachs is also a fan of this big four bank. Its analysts currently have a buy rating and $34.81 price target on its shares.

The broker is positive on NAB due to its exposure to commercial lending, which it expects to perform better than home lending in the current environment. Goldman also notes that the work NAB has done on productivity and cost management "leaves it well positioned for an environment of elevated inflationary pressure."

In respect to dividends, Goldman Sachs is expecting NAB to pay fully franked dividends of $1.66 per share in FY 2023 and $1.73 per share in FY 2024. Based on the current NAB share price of $29.76, this means yields of 5.6% and 5.8%, respectively.

The post Buy NAB and this ASX dividend share for a passive income boost: analysts appeared first on The Motley Fool Australia.

Creating a passive income stream would be on many New Year's resolution lists this year. Investors like you and I will be scouring the markets for dividend-paying investments to line our pockets.

However, the humble small-cap shares of the ASX are often overlooked during this undertaking.

It is important to remember there are more dividend opportunities in the Aussie market than just the big four banks and a few mining giants. Why is it important?… Because if you're looking at a long time horizon, small-caps — on average — outperform the big end of town.

In my mind, that's the equivalent of having your cake and eating it too! After all, there is no rule in investing that says you can't have dividends and growth.

Which ASX small-caps I'd buy for passive income

To try and capture the best of both worlds, I've whittled my way down to two ASX small-cap shares that could provide phenomenal income. To make the list, these companies needed a market capitalisation between $300 million to $2 billion and provide a yield above 4%.

HealthCo Healthcare and Wellness REIT (ASX: HCW)

This first one is a little different from the rest, being a real estate investment trust (REIT). The HealthCo REIT was spun up by the HMC Capital team — the team behind the successful acquisition and repurposing of the former Masters' portfolio from Woolworths in 2017.

As the name suggests, the REIT is focused on developing and managing a high-quality property portfolio leasing to a variety of healthcare tenants. These tenants include Chemist Warehouse, Griffith University, G8 Education, and Uniting Care Queensland.

Furthermore, the high occupancy of 99% and weighted average lease expiry (WALE) of 10.2 years are reassuring metrics for passive income certainty. This ASX small-cap share currently offers a dividend yield of 4.3%.

Smartgroup Corporation Ltd (ASX: SIQ)

Next up is a company that has had its share price battered and bruised over the past year. Shares in the salary packaging and novated leasing provider have sank 31% compared to a year ago, as shown below.

Relatively flat revenue and the loss of its contract with the Department of Education and Training Victoria have rattled shareholders. Nevertheless, the company has a proven history of delivering earnings and dividend growth.

At a price-to-earnings (P/E) ratio of 10.5, Smartgroup looks like a value opportunity for passive income and further upside. The trailing dividend yield is around 12.8%.

While I suspect this will fall in 2023, I believe dividends will still be solid thanks to Smartgroup's thick profit margin — typically above 20%.

The post Hunting for passive income among ASX small-cap shares? Here are my top 2 picks appeared first on The Motley Fool Australia.

Both have been named as buys by analysts at Goldman Sachs and tipped to provide attractive yields. Here's what you need to know about them:

Healthco Healthcare and Wellness REIT (ASX: HCW)

The first ASX dividend share that Goldman Sachs has tipped as a buy is the Healthco Healthcare and Wellness REIT.

It is a health and wellness focused real estate investment trust that invests in hospitals, aged care, childcare, government, life sciences and research, and primary care and wellness properties.

Goldman currently has a conviction buy rating and $2.14 price target on its shares. It likes Healthco Healthcare and Wellness due to its strong balance sheet and its exposure to government-backed sub-sectors. All in all, the broker believes this makes it one of the "top picks in the sector."

Its analysts also expect some attractive yields from its shares in the near term. The broker has pencilled in dividends per share of 7.5 cents in both FY 2023 and FY 2024. Based on the current Healthco Healthcare and Wellness REIT unit price of $1.70, this will mean yields of 4.4% for investors.

Universal Store Holdings Ltd (ASX: UNI)

Another ASX dividend share that Goldman Sachs rates highly is Universal Store.

It is a growing retailer focused predominately on the youth apparel industry through its Universal Store and Thrills brands.

Like many retail shares, Universal Store's shares haven fallen heavily this year due to concerns over consumer spending amid the cost of living crisis.

Goldman Sachs believes this could have created a buying opportunity and recently put a buy rating and $7.30 price target on its shares. Its analysts believe that Universal Store's target demographic will be less impacted by rising interest rates. In addition, they stand to benefit from an increase in the minimum wage.

Goldman is expecting this to lead to the company paying fully franked dividends of 26.1 cents in FY 2023 and 29.9 cents in FY 2024. Based on the latest Universal Store share price of $5.19, this equates to yields of 5% and 5.8%, respectively.

The post 2 ASX dividend shares to buy right now: Goldman Sachs appeared first on The Motley Fool Australia.

But which shares should you buy? Two that have been recently rated as buys and tipped to provide attractive yields are listed below.

Here's why experts say they could be worth owning:

Baby Bunting Group Ltd (ASX: BBN)

This leading baby products retailer could be an ASX dividend share to buy according to analysts at Morgans.

Although Baby Bunting is having a tough time in FY 2023, the broker remains positive and sees its share price weakness as a buying opportunity. So much so, its analysts have recently put an add rating and $3.60 price target on its shares. Morgans said:

With the shares nearly 30% lower than they were before the AGM, there has, in our view, been an overreaction to the update. BBN is still the largest specialist in a comparatively defensive retail segment. It still has compelling opportunities to grow its share of a growing market through store rollout, entry into New Zealand, range expansion and the launch of an online marketplace. It's trading on 12x FY24 P/E. ADD.

As for dividends, the broker is forecasting fully franked dividends per share of 14 cents in FY 2023 and then 16 cents in FY 2024. Based on the current Baby Bunting share price of $2.70, this will mean yields of 5.2% and 5.9%, respectively.

Healthco Healthcare and Wellness REIT (ASX: HCW)

The Healthco Healthcare and Wellness REIT could be another ASX dividend share to buy.

That's the view of analysts at Goldman Sachs, which think very highly of the health and wellness focused real estate investment trust. In fact, the broker has put a coveted conviction buy rating on its shares with a price target of $2.05.

Goldman likes the company due to its strong balance sheet, positive tenant mix, and the resilient valuations in the healthcare sector. It explained:

[T]he REIT remains one of our top picks in the sector given 1) its net cash position with over $450mn of liquidity, providing flexibility for near term opportunities, 2) its diversified mix of strong tenant covenants in sub-sectors that are majority government-backed across the care spectrum, mitigating potential tenant credit risks, 3) Healthcare and childcare assets valuations have remained resilient, 4) the expansive forecast future demand for assets across the care spectrum, underpinning development opportunities, and 5) inexpensive valuation.

In respect to dividends, Goldman expects dividends per share of 7.5 cents in both FY 2023 and FY 2024. Based on the current Healthco Healthcare and Wellness REIT unit price of $1.70, this will mean yields of 4.4% for investors.

The post Buy these ASX dividend shares for a passive income boost in 2023 – experts appeared first on The Motley Fool Australia.

Both dividend shares are rated as buys and expected to provide investors with attractive yields in the near term. Here's what you need to know about them:

Healthco Healthcare and Wellness REIT (ASX: HCW)

The first ASX dividend share to look at is the Healthco Healthcare and Wellness REIT.

Goldman Sachs is a fan of this health and wellness focused real estate investment trust. This is due to its strong balance sheet, positive tenant mix, and the resilient valuations in the healthcare sector. It commented:

[T]he REIT remains one of our top picks in the sector given 1) its net cash position with over $450mn of liquidity, providing flexibility for near term opportunities, 2) its diversified mix of strong tenant covenants in sub-sectors that are majority government-backed across the care spectrum, mitigating potential tenant credit risks, 3) Healthcare and childcare assets valuations have remained resilient, 4) the expansive forecast future demand for assets across the care spectrum, underpinning development opportunities, and 5) inexpensive valuation.

Goldman has a conviction buy rating and $2.05 price target on its shares.

In addition, the broker is forecasting dividends per share of 7.5 cents in both FY 2023 and FY 2024. Based on the current Healthco Healthcare and Wellness REIT unit price of $1.69, this will mean yields of 4.4% for income investors.

Rural Funds Group (ASX: RFF)

Another ASX dividend share that could be a buy is Rural Funds.

It is an agricultural focused real estate investment trust (REIT) that owns a portfolio of assets across a number of agricultural industries. These include orchards, vineyards, water entitlements, cropping, and cattle farms.

Bell Potter is positive on the company and believes its shares are trading at a very inviting level. It recently commented:

Discounts of this magnitude to adjusted NVA have only been seen in the period after its compliance listing (2014-15) and following the issue of the Bonitas short report (in Aug-Sep'19). To this end the current discount to adjusted NAV reflects what historically would be considered an attractive entry point and we upgrade our rating from Hold to Buy.

The broker currently has a buy rating and $2.75 price target on Rural Funds shares.

As for dividends, it is forecasting an 11.7 cents per share dividend in FY 2023 and then a 12.7 cents per share dividend in FY 2024. Based on the current Rural Funds share price of $2.46, this represents yields of 4.75% and 5.15%, respectively.

The post Buy these ASX dividend shares for a passive income boost: analysts appeared first on The Motley Fool Australia.

Both of these ASX dividend shares have recently been named as buys by brokers. Here's why they could be worth considering next week:

Healthco Healthcare and Wellness REIT (ASX: HCW)

According to a recent note out of Goldman Sachs, its analysts believe the Healthco Healthcare and Wellness REIT is in the buy zone for income investors. The broker currently has a conviction buy rating and $2.05 price target on the health and wellness focused real estate investment trust's shares.

Goldman likes the company due to its strong balance sheet, positive tenant mix, and the resilient valuations in the healthcare sector. It is also positive on the future, noting that "the expansive forecast future demand for assets across the care spectrum, underpinning development opportunities."

As for dividends, the broker is expecting dividends per share of 7.5 cents in both FY 2023 and FY 2024. Based on the current Healthco Healthcare and Wellness REIT unit price of $1.70, this will mean yields of 4.4%.

Woolworths Limited (ASX: WOW)

Analysts at Citi have named this retail giant as a buy. According to the note, the broker has put a buy rating and $39.50 price target on its shares.

Its analysts appear relatively pleased with Woolworths' decision to swap pokie machines for pet food and accessories following the acquisition of a 55% stake in Petspiration Group which will be funded from the partial selldown of its Endeavour Group Ltd (ASX: EDV) stake.

Outside this, the broker remains positive on Woolworths' outlook and is forecasting double digit earnings growth in FY 2023 and FY 2024.

It expects this to lead to fully franked dividends per share of 104 cents in FY 2023 and 114 cents in FY 2024. Based on the current Woolworths share price of $34.31, this will mean yields of 3% and 3.3%, respectively.

The post Brokers name 2 ASX dividend shares to buy next week appeared first on The Motley Fool Australia.

Ask A Fund Manager

The Motley Fool chats with the best in the industry so that you can get an insight into how the professionals think. In this edition, Tribeca Investment Partners portfolio manager Simon Brown reveals the two shares he'd snap up now at a 40% discount.

Cut or keep?

The Motley Fool: Let's examine three ASX shares that have been devastated this year and see if you think each of these fallen stars is now a bargain to pick up or if you'd stay away.

The first one is Life360 Inc (ASX: 360), which has dropped almost 40% in the past 12 months. What do you think?

Simon Brown: Yeah, similar to comments that I made with relation to NextDC Ltd (ASX: NXT), in terms of a high growth business where discount rates went up, cost of money increased, and you've seen a reasonably violent de-rating. 

It probably doesn't help that it hadn't been necessarily profitable. It is investing for growth and spending quite a bit of money — and those growth rates are very high. So as an investor, if they can continue to invest money to generate those rates of growth, you've got to be reasonably happy.

But you've seen names within the sector that have held up far better. Some of those larger growth names haven't come off nearly as much as Life360 has, and there's probably a bit of a difference there that those ones have reasonable levels of cash generation and profits.

I guess there was a misstep somewhere. It was with the acquisition of Tile, which probably hasn't performed to expectations that were laid out when they made the acquisition. That's baked into the share price as it is now. But it also puts pressure on the business to look to make that acquisition work. 

And they've got a program coming up where they're going to bundle Tiles for new subscribers to incentivise customers to sign up to their membership plans. So that's looking to be rolled out in calendar year 2023. We think that should be an opportunity to continue to monetise their user base and potentially lift the level of profitability.

They just raised money, you might have seen in the press just recently. Given that they've got that trajectory towards cash positive later in calendar year 2023, they thought it was prudent to raise some money just to make sure if economic impacts in the US or the like had an impact on growth. 

So that's a name we've been on record as saying we've been quite supportive of throughout its journey since COVID, when they were able to demonstrate they were quite resilient in a downturn. It's a name that we've really, really liked and we are supportive of what that business is doing.

MF: Do you still hold it?

SB: Yes, we do.

MF: Fantastic. Next one is Dusk Group Ltd (ASX: DSK), which has fallen about 40% this year. What do you reckon about that one?

SB: Consumer discretionary has been a challenging area to get a huge amount of confidence, in terms of investment. 

I think that the most recent update was strong — ahead of where analyst expectations are. But I guess that there's a couple of things. It is a little bit challenging to get a true read on the rate of growth given that we had the Delta lockdowns last year, in that first quarter of FY22. So the run rate comparisons are hard to get an underlying feeling of the true rate of growth, given that the prior comparable period was very depressed.

Secondly, given the level of inflation that's been coming through, particularly for domestic retailers such as Dusk, who import a lot of their products that they sell, there has been a lot of price inflation. That is clouding the ability to see the true underlying volume of sales. We suspect that's probably weaker than the nominal sales that are being recorded. 

If you are coming into a period where that rate of inflation is slowing, the higher rates are pressuring consumers and they're more thoughtful about what they're buying, it potentially puts pressure on some of these retailers. They'll be forced back into some degree of discounting and it could prove problematic for margins.

Expectations aren't particularly lofty for the space, but given how leveraged they are with cost bases very much skewed towards wages and rent, both of which are escalating reasonably strongly, it doesn't take a huge amount of disappointment at that sales level to translate into meaningful movements in profit.

So yeah, we're on the sidelines there, just waiting for the interest rate rises that started in March to flow through into consumers. You tend to start to see the impacts around nine months after the first rate rise. We are watching very closely there as to how much of an impact we see on consumers and how that will relate to future earnings for companies like Dusk.

MF: Fair enough. The last one, which has also plunged about 40% this year is HMC Capital Ltd (ASX: HMC).

SB: That's the old HomeCo. It's a property funds management business. They've got two listed REITs — HomeCo Daily Needs REIT (ASX: HDN) and the Healthco Healthcare and Wellness REIT (ASX: HCW) — so they're an alternative asset manager. 

We think David Di Pilla's done a good job there to date. We're a big fan of the funds management model in property. You've obviously got some very successful examples of that model in Charter Hall Group (ASX: CHC) and Centuria Capital Group (ASX: CNI). 

[HMC Capital] emanated out of small caps that we've invested in previously, that have done very well for our fund. We identified HomeCo as a name that was coming off a smaller base. They had lower levels of invested assets, meaning that as they looked to grow via acquisition, those acquisitions can have a more meaningful impact on growth. 

So that's a name that we quite like. They continue to accumulate properties and start new funds. 

Look, there has been a property cycle within REIT to some degree. You've had interest rates going up, which should flow through to lower property values via an increase in cap rates there. There's been a degree of value destruction across that REIT space, where a number of the names are trading at fairly steep discounts to their last reported net tangible assets.

You'd argue there's a degree of devaluation in their properties already imputed in the share price. And we think once rates plateau and start to come back down — as they inevitably will as economic growth slows — there's probably an opportunity for the space, including HMC, to pick up a tailwind there. And do better given the underperformance of the whole space over the last 12 months.

The post 40% sale! 2 cheap ASX shares to buy for a better 2023: fundie appeared first on The Motley Fool Australia.

Here's what you need to know about these ASX dividend shares today:

Healthco Healthcare and Wellness REIT (ASX: HCW)

The first ASX dividend share that Goldman Sachs has tipped as a buy is Healthco Healthcare and Wellness.

Goldman believes the health and wellness focused real estate investment trust is well-placed to pay attractive dividends in the coming years thanks to its strong balance sheet and exposure to government-backed sub-sectors. The broker said:

[T]he REIT remains one of our top picks in the sector given 1) its net cash position with over $450mn of liquidity, providing flexibility for near term opportunities, 2) its diversified mix of strong tenant covenants in sub-sectors that are majority government-backed across the care spectrum, mitigating potential tenant credit risks, 3) Healthcare and childcare assets valuations have remained resilient, 4) the expansive forecast future demand for assets across the care spectrum, underpinning development opportunities, and 5) inexpensive valuation.

In respect to dividends, Goldman expects dividends per share of 7.5 cents in both FY 2023 and FY 2024. Based on the current Healthco Healthcare and Wellness REIT unit price of $1.66 this will mean yields of 4.5% for investors.

Goldman has a conviction buy rating and $2.14 price target on its shares.

Westpac Banking Corp (ASX: WBC)

Another ASX dividend share that Goldman Sachs rates highly is Australia's oldest bank, Westpac.

Goldman believes that Westpac is well-placed to benefit from a combination of rising interest rates and its cost cutting plans. It commented:

We remain Buy (on CL) rated on WBC given: i) while on the surface, the FY22 result suggested WBC's NIM leverage was underwhelming relative to some peers, we think 2H22 was adversely impacted by late-in-the-half liquidity build, and management's guidance on its FY23 NIM trajectory was better than we had previously anticipated, ii) despite WBC revising its FY24E cost target to A$8.6 bn (from A$8.0 bn), the bank's performance on cost management remains strong in this inflationary environment with a 9% step down in costs expected over the next two years

Its analysts are expecting this to lead to fully franked dividends per share of 148.4 cents in FY 2023 and 160 cents in FY 2024. Based on the current Westpac share price of $23.76, this will mean yields of 6.25% and 6.7%, respectively.

Goldman Sachs has a conviction buy rating and $27.60 price target on the bank's shares.

The post Buy Westpac and this ASX dividend share: broker appeared first on The Motley Fool Australia.

Both of these ASX dividend shares have recently been named as buys. Here's why experts say they could be worth considering:

Baby Bunting Group Ltd (ASX: BBN)

The first ASX dividend share for income investors to consider is leading baby products retailer Baby Bunting.

Analysts at Morgans remain positive on the company and currently have an add rating and $3.60 price target on its shares. While disappointed with its first quarter margins, the broker feels that its shares have been oversold. It said:

With the shares nearly 30% lower than they were before the AGM, there has, in our view, been an overreaction to the update. BBN is still the largest specialist in a comparatively defensive retail segment. It still has compelling opportunities to grow its share of a growing market through store rollout, entry into New Zealand, range expansion and the launch of an online marketplace. It's trading on 12x FY24 P/E. ADD.

In respect to dividends, the broker is forecasting fully franked dividends per share of 14 cents in FY 2023 and then 16 cents in FY 2024. Based on the current Baby Bunting share price of $2.56, this will mean yields of 5.5% and 6.3%, respectively.

Healthco Healthcare and Wellness REIT (ASX: HCW)

Another ASX dividend share to look at is the Healthco Healthcare and Wellness REIT.

Goldman Sachs is a fan of this health and wellness focused real estate investment trust and has a conviction buy rating and $2.05 price target on its shares.

The broker likes the company due to its strong balance sheet, positive tenant mix, and the resilient valuations in the healthcare sector. It commented:

[T]he REIT remains one of our top picks in the sector given 1) its net cash position with over $450mn of liquidity, providing flexibility for near term opportunities, 2) its diversified mix of strong tenant covenants in sub-sectors that are majority government-backed across the care spectrum, mitigating potential tenant credit risks, 3) Healthcare and childcare assets valuations have remained resilient, 4) the expansive forecast future demand for assets across the care spectrum, underpinning development opportunities, and 5) inexpensive valuation.

As well as decent upside, Goldman is expecting attractive dividend yields from the Healthco Healthcare and Wellness REIT.

It has pencilled in dividends per share of 7.5 cents in both FY 2023 and FY 2024. Based on the current Healthco Healthcare and Wellness REIT unit price of $1.58, this will mean yields of 4.75% for income investors.

The post Experts say these ASX dividend shares are buys today appeared first on The Motley Fool Australia.

Here's why these ASX dividend shares have been tipped as buys by Goldman Sachs:

Healthco Healthcare and Wellness REIT (ASX: HCW)

The first ASX dividend share to look at is the Healthco Healthcare and Wellness REIT.

As you might have guessed from its name, it is a real estate investment trust with a focus on health and wellness assets such as hospitals, aged care, childcare, life sciences, and primary care properties.

Goldman Sachs is very positive on the company and has a conviction buy rating and $2.05 price target on its shares.

The broker named four reasons that it is positive. It said:

[T]he REIT remains one of our top picks in the sector given 1) its net cash position with over $450mn of liquidity, providing flexibility for near term opportunities, 2) its diversified mix of strong tenant covenants in sub-sectors that are majority government-backed across the care spectrum, mitigating potential tenant credit risks, 3) Healthcare and childcare assets valuations have remained resilient, 4) the expansive forecast future demand for assets across the care spectrum, underpinning development opportunities, and 5) inexpensive valuation.

Goldman expects dividends per share of 7.5 cents in both FY 2023 and FY 2024. Based on the current Healthco Healthcare and Wellness REIT unit price of $1.59, this will mean yields of 4.7% for investors.

HomeCo Daily Needs REIT (ASX: HDN)

HomeCo Daily Needs is another real estate investment trust that Goldman Sachs is bullish on.

It has a focus on metro-located, convenience-based assets across neighbourhood retail, large format retail, and health and services.

The broker believes that its shares are cheap at current levels and has a buy rating and $1.57 price target on them. It commented:

We continue to believe HDN is undervalued at its current valuation given its diversified tenant base, and see it as well positioned to benefit from the shift to omni channel retailing, with additional external growth opportunities to drive earnings growth over the medium-term.

As for dividends, Goldman is forecasting dividends of 8.3 cents per share in FY 2023 and 8.5 cents per share in FY 2024. Based on the current HomeCo Daily Needs REIT unit price of $1.28, this will mean yields of 6.5% and 6.65%, respectively.

The post Buy these ASX dividend shares now: Goldman Sachs appeared first on The Motley Fool Australia.

Both have been named as buys by analysts and tipped to provide attractive yields. Here's what you need to know about them:

Dicker Data Ltd (ASX: DDR)

The first ASX dividend share to look at is Dicker Data. It is one of the largest technology hardware, software, cloud, cybersecurity, access control and surveillance distributors in Australia and New Zealand.

Dicker Data could be a quality option for income investors thanks to its long track record of earnings and dividend growth and its positive long-term outlook. The latter is being supported by the recent expansion of its warehouse by 70%. This provides a significant runway to capture additional growth in the coming years and is also expected to deliver cost savings.

Morgan Stanley is positive on the company and recently retained its outperform rating and $14.00 price target on its shares.

As for dividends, its analysts are forecasting fully-franked dividends per share of 35.3 cents in FY 2022 and 40.5 cents in FY 2023. Based on the latest Dicker Data share price of $9.89, this will mean yields of 3.6% and 4.1%, respectively.

Healthco Healthcare and Wellness REIT (ASX: HCW)

Another ASX dividend share that has been tipped as a buy is Healthco Healthcare and Wellness REIT.

It is a health and wellness focused real estate investment trust that invests in hospitals, aged care, childcare, government, life sciences and research, and primary care and wellness properties.

Goldman Sachs is a fan of the company and has a conviction buy rating and $2.14 price target on its shares. Goldman likes Healthco Healthcare and Wellness due to its strong balance sheet and its exposure to government-backed sub-sectors. In fact, the broker said that these qualities make it "one of our top picks in the sector."

In respect to dividends, Goldman expects dividends per share of 7.5 cents in both FY 2023 and FY 2024. Based on the current Healthco Healthcare and Wellness REIT unit price of $1.41, this will mean yields of 5.3% for investors.

The post Analysts name 2 ASX dividend shares to buy right now appeared first on The Motley Fool Australia.

Both have been named as buys by brokers and tipped to provide big yields. Here's what you need to know about them:

Accent Group Ltd (ASX: AX1)

The first ASX dividend share that has been tipped as a buy is footwear retailer Accent.

The team at Morgans is positive on the company and has an add rating and $2.00 price target on its shares. The broker likes Accent due to its attractive valuation and belief that the company is well-placed to bounce back from a very difficult time in FY 2022.

Its analysts said:

AX1's renewed focus on selling at full price will, in our view, support a recovery in the gross profit margin in FY23 back towards historical averages. We welcome AX1's moderation of the pace of its store rollout in favour of a more selective expansion strategy focused on return on investment. We see AX1 as undervalued at the current share price.

As for dividends, Morgans is forecasting fully franked dividends of 9 cents per share in FY 2023 and 11 cents per share in FY 2024. Based on the current Accent share price of $1.48, this will mean yields of 6.1% and 7.4%, respectively.

Healthco Healthcare and Wellness REIT (ASX: HCW)

Another ASX dividend share that has been tipped as a buy is this health and wellness focused real estate investment trust.

Analysts at Goldman Sachs are very positive on the company and have a conviction buy rating and $2.14 price target on its shares. Goldman likes Healthco Healthcare and Wellness due to its strong balance sheet and its exposure to government-backed sub-sectors.

The broker said:

[T]he REIT remains one of our top picks in the sector given 1) its net cash position with over $450mn of liquidity, providing flexibility for near term opportunities, 2) its diversified mix of strong tenant covenants in sub-sectors that are majority government-backed across the care spectrum, mitigating potential tenant credit risks, 3) Healthcare and childcare assets valuations have remained resilient, 4) the expansive forecast future demand for assets across the care spectrum, underpinning development opportunities, and 5) inexpensive valuation.

In respect to dividends, Goldman expects dividends per share of 7.5 cents in both FY 2023 and FY 2024. Based on the current Healthco Healthcare and Wellness REIT unit price of $1.41, this will mean yields of 5.3% for investors.

The post Brokers name 2 ASX dividend shares to buy with big yields appeared first on The Motley Fool Australia.

Here's why these ASX dividend shares are rated as buys:

Healthco Healthcare and Wellness REIT (ASX: HCW)

The first ASX dividend share to look at is the Healthco Healthcare and Wellness REIT.

As you might have guessed from its name, it is a real estate investment trust with a focus on healthcare and wellness assets such as hospitals, aged care, childcare, life sciences, and primary care properties.

Goldman Sachs is very positive on the company and has a conviction buy rating and $2.08 price target on its shares. It believes the company is one of the best options in the sector for several reasons. It explained:

[Healthco Healthcare and Wellness] remains one of our top picks in the sector given 1) its net cash position with over $450mn of liquidity, providing flexibility for near term opportunities, 2) its diversified mix of strong tenant covenants in sub-sectors that are majority government-backed across the care spectrum, mitigating potential tenant credit risks, 3) Healthcare and childcare assets valuations have remained resilient, 4) the expansive forecast future demand for assets across the care spectrum, underpinning development opportunities, and 5) inexpensive valuation.

The broker is also expecting some attractive dividend yields in the near term. Goldman is forecasting dividends per share of 7.5 cents in both FY 2023 and FY 2024. Based on the current Healthco Healthcare and Wellness REIT unit price of $1.43, this will mean yields of 5.35% for investors.

Transurban Group (ASX: TCL)

Another ASX dividend share that could be a top option for income investors is Transurban.

It is one of the world's leading toll road operators with a portfolio of important roads and a lucrative pipeline of development projects.

Morgans is a fan of the company and has it on its best ideas list with a $13.85 price target. The broker likes Transurban due to regional population, employment growth, urbanisation, and positive exposure to inflation. It commented:

TCL owns a pure play portfolio of toll road concession assets located in Melbourne, Sydney, Brisbane, and North America. This provides exposure to regional population and employment growth and urbanisation. Given very high EBITDA margins, earnings are driven by traffic growth (with recovery from COVID) and toll escalation (roughly 70% by at least CPI and approximately one-quarter at a fixed c.4.25% pa). We think TCL will continue to be attractive to investors given its market cap weighting (important for passive index tracking flows), the high quality of its assets, management team, balance sheet, and growth prospects

As for dividends, Morgans expects dividends per share of 53.4 cents in FY 2023 and then 65.8 cents in FY 2024. Based on the current Transurban share price of $12.55, this implies yields of 4.25% and 5.25%, respectively.

The post 2 excellent ASX dividend shares that analysts love in October appeared first on The Motley Fool Australia.

Here's what you need to know about these top ASX dividend shares:

Healthco Healthcare and Wellness REIT (ASX: HCW)

According to a recent note out of Goldman Sachs, its analysts have put a conviction buy rating and $2.08 price target on this real estate investment trust's shares.

Goldman likes Healthco Healthcare and Wellness REIT, which has a focus on hospitals, aged care, childcare, life sciences, and primary care properties, due to its robust balance sheet, favourable tenant mix, the resilience of healthcare and childcare assets, and the expected strong future demand for assets across the care spectrum.

In addition, the broker is expecting some attractive yields from its shares in the coming years. It has pencilled in dividends per share of 7.5 cents in both FY 2023 and FY 2024. Based on the current Healthco Healthcare and Wellness REIT unit price of $1.39, this will mean yields of 5.4% for investors.

Super Retail Group Ltd (ASX: SUL)

A recent note out of Morgans reveals that its analysts have retained their add rating on this retail conglomerate's shares with an improved price target of $13.00.

Morgans remains positive on the company and is expecting a solid first half to FY 2023. Particularly given its "much more resilient earnings in FY22 than had been forecast" and the fact that there are "no signs yet that the consumer is pulling back in Australia."

The broker is expecting this to underpin further generous dividend payments for this financial year and beyond. It is forecasting fully franked dividends per share of 56 cents in FY 2023 and 58 cents in FY 2024. Based on the latest Super Retail share price of $8.88, this will mean yields of 6.3% and 6.5%, respectively.

The post Brokers name 2 top ASX dividend shares to buy this month appeared first on The Motley Fool Australia.

Two that have done enough to impress analysts are listed below. Here's why they have been given the thumbs up:

Healthco Healthcare and Wellness REIT (ASX: HCW)

The first ASX dividend share that analysts are tipping as a buy is the Healthco Healthcare and Wellness REIT.

As its name implies, this real estate investment trust has a focus on hospitals, aged care, childcare, life sciences, and primary care properties.

The team at Goldman Sachs is very positive on the company and recently named it as one of its top picks in the sector. This is due to its robust balance sheet and strong tenant base. Goldman explained:

[T]he REIT remains one of our top picks in the sector given 1) its net cash position with over $450mn of liquidity, providing flexibility for near term opportunities, 2) its diversified mix of strong tenant covenants in sub-sectors that are majority government-backed across the care spectrum, mitigating potential tenant credit risks, 3) Healthcare and childcare assets valuations have remained resilient, 4) the expansive forecast future demand for assets across the care spectrum, underpinning development opportunities, and 5) inexpensive valuation.

The broker currently has a conviction buy rating and $2.08 price target on its shares.

As for dividends, its analysts are forecasting dividends per share of 7.5 cents in both FY 2023 and FY 2024. Based on the current Healthco Healthcare and Wellness REIT unit price of $1.66, this will mean yields of 4.5% for investors.

Whitehaven Coal Ltd (ASX: WHC)

Another ASX dividend share that analysts are tipping as a buy is coal miner Whitehaven Coal.

It is expected to provide investors with some very big dividend yields in the near term thanks to sky high coal prices. In fact, the team at Morgans has described them as "supercharged returns." It commented:

We see strong potential for a more prolonged dislocation in energy markets where supply security commands a higher premium for longer. WHC offers ~2%/24% upside to our base/bull case pricing scenarios (excluding growth assets) with clear upside risks to valuation and dividends. Note that thermal coal futures pricing currently sits well above our "super-bull" price scenario, which supports an NPV towards $11.00ps.

The broker currently has an add rating and $8.60 price target on the company's shares.

In respect to dividends, Morgans is forecasting dividends per share of 100 cents in FY 2023 and 64 cents in FY 2024. Based on the latest Whitehaven Coal share price of $8.31, this will mean yields of 12% and 7.7%, respectively.

The post Analysts name 2 ASX dividend shares to buy this month appeared first on The Motley Fool Australia.

Here's why these ASX dividend shares have been tipped as buys:

Dexus Industria REIT (ASX: DXI)

The first ASX dividend share that could be in the buy zone is Dexus Industria.

It is an industrial and office focused property company that was formerly known as APN Industria. Dexus Industria owns interests in office and industrial properties across the country that provide functional and affordable workspaces for businesses.

Morgans is a fan of the company. It recently commented:

Its analysts currently have an add rating and $3.25 price target on the company's shares.

They are also forecasting attractive dividends per share of 17.3 cents in FY 2023 and 16.4 cents in FY 2024. Based on the current Dexus Industria share price of $2.70, this will mean yields of 6.4% and 6.1%, respectively.

Healthco Healthcare and Wellness REIT (ASX: HCW)

Another ASX dividend share that has been named as a buy is the Healthco Healthcare and Wellness REIT.

It is a real estate investment trust with a focus on hospitals, aged care, childcare, life sciences, and primary care properties.

Goldman Sachs is very positive on the company and recently named it as one of its top picks in the sector. The broker commented:

[T]he REIT remains one of our top picks in the sector given 1) its net cash position with over $450mn of liquidity, providing flexibility for near term opportunities, 2) its diversified mix of strong tenant covenants in sub-sectors that are majority government-backed across the care spectrum, mitigating potential tenant credit risks, 3) Healthcare and childcare assets valuations have remained resilient, 4) the expansive forecast future demand for assets across the care spectrum, underpinning development opportunities, and 5) inexpensive valuation.

Its analysts have a conviction buy rating and $2.14 price target on its shares.

In respect to dividends, Goldman expects dividends per share of 7.5 cents in both FY 2023 and FY 2024. Based on the current Healthco Healthcare and Wellness REIT unit price of $1.65 this will mean yields of 4.5% for investors.

The post Here are 2 ASX dividend shares experts say are buys appeared first on The Motley Fool Australia.

This has led to countless recommendations being made in regard to which shares investors should buy or sell now.

Two dividend shares that have done enough to impress brokers are listed below. Here's why they have been given the thumbs up by analysts:

Australia and New Zealand Banking Group (ASX: ANZ)

According to a note out of Citi, its analysts believe this banking giant's shares are great value at the current level.

Citi currently has a buy rating and $29.00 price target on the bank's shares.

The broker sees positives from ANZ's plan to acquire the banking operations of Suncorp Group Ltd (ASX: SUN). It highlights that the deal meets a strategic objective and is being undertaken at a reasonable purchase price.

As for dividends, Citi is forecasting fully franked dividends per share of 144 cents in FY 2022 and then 165 cents in FY 2023. Based on the current ANZ share price of $22.64, this implies yields of 5.7% and 6.6%, respectively, over the next two years.

Healthco Healthcare and Wellness REIT (ASX: HCW)

A note out of Goldman Sachs reveals that its analysts are bullish on the Healthco Healthcare and Wellness REIT. It is a real estate investment trust with a focus on hospitals, aged care, childcare, life sciences, and primary care properties.

Goldman currently has a conviction buy rating and $2.08 price target on its shares.

Its analysts rate the REIT highly due to its robust balance sheet, favourable tenant mix, the resilience of healthcare and childcare assets, the expected strong future demand for assets across the care spectrum, and its attractive valuation.

In addition, the broker is forecasting good yields from Healthco Healthcare and Wellness. It expects dividends per share of 7.5 cents in both FY 2023 and FY 2024. Based on the current Healthco Healthcare and Wellness REIT unit price of $1.78, this will mean yields of 4.2% for investors.

The post Brokers name 2 ASX dividend shares to buy this month appeared first on The Motley Fool Australia.